CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 31 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Salt Lake City, Utah, United States and 94 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Salt Lake City, Utah, United States and 215 other locations
Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood cells). The purpose ...
Phase 1
West Valley City, Utah, United States and 2 other locations
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Salt Lake City, Utah, United States and 67 other locations
comprise 2 cohorts to assess safety and efficacy of emavusertib in combination with ibrutinib in patients with primary central nervous system lymphoma...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 41 other locations
Phase 2 dose (RP2D) in patients with relapsed or refractory (R/R) lymphomas and solid tumors. The secondary objectives are to characterize t...
Phase 1
West Valley City, Utah, United States of America and 1 other location
The purpose of this study was to evaluate whether copanlisib in combination with rituximab is superior to placebo in combination with rituximab in pr...
Phase 3
Salt Lake City, Utah, United States and 186 other locations
This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...
Phase 3
Salt Lake City, Utah, United States and 226 other locations
plus venetoclax (AV) versus venetoclax plus obinutuzumab (VO) in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma...
Phase 3
Salt Lake City, Utah, United States and 37 other locations
Clinical trials
Research sites
Resources
Legal